Smith, Charles D.
Apogee Biotechnology Corporation,
United States
2025 Rank: 144289
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 5374 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 144289 | 146502 |
| Total Cites | 7545 | 8480 |
| H-index | 51 | 54 |
| Hm-index | 20 | 20 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 7 | 10 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 839 | 915 |
| Number of Single+First+Last Authored Papers | 83 | 83 |
| Total Cites to Single+First+Last Authored Papers | 4517 | 4960 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5301 | 5648 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.50 |
| Self-Citation Percentage |
11.03%
|
|
Smith, Charles D.
Apogee Biotechnology Corporation,
United States
2024 Rank: 140815
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 5309 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 140815 | 141540 |
| Total Cites | 7236 | 8132 |
| H-index | 50 | 53 |
| Hm-index | 20 | 20 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 6 | 9 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 806 | 880 |
| Number of Single+First+Last Authored Papers | 81 | 81 |
| Total Cites to Single+First+Last Authored Papers | 4338 | 4762 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5065 | 5406 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.50 |
| Self-Citation Percentage |
11.02%
|
|
Smith, Charles D.
Apogee Biotechnology Corporation,
United States
2022 Rank: 128082
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 4907 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 128082 | 129182 |
| Total Cites | 6542 | 7321 |
| H-index | 46 | 49 |
| Hm-index | 19 | 19 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 6 | 9 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 761 | 832 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 3980 | 4347 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4570 | 4893 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.50 |
| Self-Citation Percentage |
10.64%
|
|
Smith, Charles D.
Penn State College of Medicine,
United States
2021 Rank: 127578
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 4917 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 127578 | 128075 |
| Total Cites | 6329 | 7102 |
| H-index | 45 | 47 |
| Hm-index | 19 | 19 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 5 | 8 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 747 | 817 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 3857 | 4223 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4434 | 4755 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.49 |
| Self-Citation Percentage |
10.88%
|
|
Smith, Charles D.
Apogee Biotechnology Corporation,
United States
2020 Rank: 117629
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 4749 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 117629 | 117500 |
| Total Cites | 6036 | 6773 |
| H-index | 43 | 45 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 5 | 8 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 719 | 789 |
| Number of Single+First+Last Authored Papers | 79 | 79 |
| Total Cites to Single+First+Last Authored Papers | 3833 | 4198 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4255 | 4560 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.49 |
| Self-Citation Percentage |
10.88%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.